The above research corroborate the miR-15b-5p/ACSS2/PTGS2 axis in AAA pathogenesis [56], while periodontitis studies confirm COX-2 inhibition reduces alveolar bone loss [60]. Here, ACSS2 is linked to triple-A syndrome.